This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

REVOLUTIONIZING THE HUMAN MICROBIOME INDUSTRY: BIOTHERAPEUTICS DEVELOPMENTS, INNOVATIONS & COLLABORATIONS

Microbiome Therapeutics US is now a proud part of Bio-Europe -- Partner and network with key stakeholders driving innovation in pharma and biotech

Microbiome Therapeutics. Large-Scale Manufacturing. Standardization. Regulatory Considerations.

Redefining your learning experience

In light of the current global climate, it is more important than ever for the microbiome therapeutics community to connect with one another, strategize and share ideas – All in a safe, responsible way.

With our dedication to address the most pressing issues, our Microbiome Therapeutics US event has undergone a timely transformation, moving to an all-digital format and offering attendees the ability to participate in virtual content, exhibits and networking opportunities.


UNIQUE BENEFITS OF THIS ALL-VIRTUAL EVENT
UNIQUE BENEFITS OF THIS ALL-VIRTUAL EVENT
  • Customizable agenda with access to expanded session offerings
  • Convenient session scheduling for increased productivity
  • On-demand access to content and topic resources
  • Interactive presentations/panels for reinforced learning
  • Pointed problem-solving and solution sourcing
  • Broader industry benchmarking and post-event analytics/insights
  • Elevated and direct access to thought leaders and experts
POWER OF NETWORKING WITH partneringONE®
POWER OF NETWORKING WITH partneringONE®

What is partneringONE®?

Our proprietary partnering platform, partneringONE®, allows you to identify prospective partners using advanced search capabilities and manage all your meeting requests in one place. Be prepared with a pre-filled, personalized meeting schedule.

Your registration includes access to this platform and all attendees of both Microbiome Therapeutics and Bio-Europe.

See Who’s Who

  • Attendee and company profiles provide insight into the delegation and sponsoring organizations
  • Advanced search capabilities to identify opportunities and potential partners
Learn More

COMPREHENSIVE CONTENT AND DYNAMIC FEATURES
COMPREHENSIVE CONTENT AND DYNAMIC FEATURES
  • 17+ Pre-recorded Presentations that will become on-demand and made available leading up to the event
  • Live Speaker Q&A Sessions
  • Additional access to ALL Bio-Europe live sessions and on-demand content
Digital Capabilities and Features
Digital Capabilities and Features
  • Access to Virtual Environment
  • Audience Q&A
  • Live Polling
  • Expert-Led Problem-Solving
  • Virtual Networking and Partnering

EXPLORING THE HUMAN MICROBIOME TO DEVELOP NEW AND PERSONALIZED THERAPEUTICS

Top industry leaders and academics share case studies, strategies, insights and more.


Innovations and Advancements in the Microbiome Industry
Innovations and Advancements in the Microbiome Industry
  • Delve into genetically engineered microbial medicines (GEMMs)

  • Discover therapeutics opportunities emerging from natural environmental habitats

  • Discuss machine learning (ML) methods for biomarkers identification for microbiome therapeutics, diagnostics & prognostics  

Looking Ahead: What Will Be the Next Pillar for Microbiome-Based Therapeutics?
Looking Ahead: What Will Be the Next Pillar for Microbiome-Based Therapeutics?
  • Get the latest developments in the microbiome industry: hear sessions on immunology & cancer, women's health care & vaginal microbiota, oral & gut microbiomes
Addressing Regulations, Manufacturing & Commercialization Challenges
Addressing Regulations, Manufacturing & Commercialization Challenges
  • Gain insights from CBER at FDA on the regulatory considerations for microbiome-based therapeutics to enter the market  

  • Designing scale-up and manufacturing processes: end to end manufacturing issues & analytical challenges

  • What are the commercialization opportunities within the microbiome industry? Hear this panel discussion with experts in the industry from companies including Pendulum Therapeutics, Vedanta Bioscience & Impacts CA

IDENTIFY, EVALUATE, AND TARGET NEW PARTNERS WITH PARTNERINGONE®

MEET THE RIGHT PEOPLE AND ACHIEVE YOUR GOALS THROUGH ONE-TO-ONE MEETINGS

partneringONE® is the gold standard solution for your meetings.

Your registration includes access to the app and all attendees of both Microbiome Therapeutics and Bio-Europe.

CONNECT WITH KEY BUYERS AT MICROBIOME THERAPEUTICS US 2020

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.   

Contact Perri Lucatello: perri.lucatello@informa.com